← Leaderboards
Tracy Minan Frech
Veterans Health Administration
$1,410,418
Attributed
$1,538,761
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $658.1K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,538,761 · 3
VA$0 · 2
By mechanism
K23$880,660 · 1
R01$401,415 · 1
T32$256,686 · 1
I01$0 · 2
Top collaborators
- Amy S Major1 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Eric R Tkaczyk$1,587,602
- Peter Wyman Wilson$258,319
- Kelly Cho$0
- Kelly C. Vranas$0
Others in their field
Top investigators on “Systemic Scleroderma”
- Eugene W. St Clair · Duke University$24,182,181
- John Varga · University Of Illinois At Chicago$13,781,985
- Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh$11,771,501
- Judith A James · Oklahoma Medical Research Foundation$11,331,322
- Robert M Elashoff · John Wayne Cancer Institute$10,394,671
- Maria Trojanowska · Boston University Medical Campus$10,085,547
Research focus
Systemic SclerodermaOxidative StressMonitorDigitalFibrosisPredictive ValueBlood VesselsArterioleUlcerVascular DiseasesSclerodermaSkinEndotheliumAutoimmune DiseasesRandomizedDouble-Blind MethodInsightDesignMediatingMolecularClinical PracticeBiopsyBrachial ArteryEvent
Grant awards (18)
Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies$401,415
R01 · FY2025 · AR · contact PI
Interdisciplinary Training in Rheumatic Diseases$256,686
T32 · FY2025 · AR
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2025 · VA · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2024 · VA · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2023 · VA · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2021 · VA · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2021 · VA · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$175,932
K23 · FY2020 · AR · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2020 · VA · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$175,932
K23 · FY2019 · AR · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$1,000
K23 · FY2019 · AR · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2019 · VA · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$175,932
K23 · FY2018 · AR · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2018 · VA · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$175,932
K23 · FY2017 · AR · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2017 · VA · contact PI
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment$175,932
K23 · FY2016 · AR · contact PI
Systemic sclerosis (SSc) vasculopathy: Improved clinical monitoring and treatment$0
I01 · FY2016 · VA · contact PI